Volume 39, Issue 4, Pages (October 2013)

Slides:



Advertisements
Similar presentations
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Advertisements

Involvement of suppressors of cytokine signaling in toll-like receptor–mediated block of dendritic cell differentiation by Holger Bartz, Nicole M. Avalos,
Volume 26, Issue 3, Pages (March 2007)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 44, Issue 3, Pages (March 2016)
Volume 26, Issue 3, Pages (March 2007)
Volume 31, Issue 2, Pages (August 2009)
Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-γ and Interleukin-12  Edda G. Schulz, Luca Mariani, Andreas Radbruch,
Volume 15, Issue 1, Pages (January 2014)
Volume 71, Issue 5, Pages e5 (September 2018)
Volume 36, Issue 5, Pages (May 2012)
Volume 35, Issue 6, Pages (December 2011)
The UPEC Pore-Forming Toxin α-Hemolysin Triggers Proteolysis of Host Proteins to Disrupt Cell Adhesion, Inflammatory, and Survival Pathways  Bijaya K.
Norito Katoh, Fujiko Soga, Takeshi Nara, Koji Masuda, Saburo Kishimoto 
Volume 39, Issue 5, Pages (November 2013)
Volume 35, Issue 1, Pages (July 2011)
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
Volume 45, Issue 5, Pages (March 2012)
Volume 31, Issue 2, Pages (August 2009)
Volume 27, Issue 1, Pages (July 2007)
Volume 27, Issue 2, Pages (August 2007)
Volume 29, Issue 4, Pages (October 2008)
Volume 36, Issue 6, Pages (June 2012)
17β-Estradiol Enhances Vascular Endothelial Growth Factor Production and Dihydrotestosterone Antagonizes the Enhancement via the Regulation of Adenylate.
Volume 36, Issue 4, Pages (April 2012)
Volume 50, Issue 2, Pages (April 2006)
Volume 47, Issue 4, Pages e3 (October 2017)
Volume 34, Issue 5, Pages (May 2011)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 22, Issue 4, Pages (April 2005)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 27, Issue 1, Pages (July 2007)
Volume 19, Issue 7, Pages (July 2012)
Volume 24, Issue 2, Pages (February 2006)
A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-Dominant Immune Responses  Guangxun Meng, Fuping Zhang, Ivan Fuss,
Volume 50, Issue 2, Pages (April 2006)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Volume 37, Issue 6, Pages (December 2012)
Volume 34, Issue 3, Pages (March 2011)
Volume 25, Issue 5, Pages (November 2006)
Granulin Is a Soluble Cofactor for Toll-like Receptor 9 Signaling
Volume 6, Issue 6, Pages (December 2009)
C5a Negatively Regulates Toll-like Receptor 4-Induced Immune Responses
Volume 28, Issue 4, Pages (April 2008)
Volume 22, Issue 2, Pages (February 2005)
Kentaro Abe, Masatoshi Takeichi  Neuron 
Volume 32, Issue 5, Pages (May 2010)
Volume 9, Issue 5, Pages (May 2011)
Volume 32, Issue 4, Pages (April 2010)
Volume 32, Issue 1, Pages (January 2010)
Volume 65, Issue 4, Pages e4 (February 2017)
Volume 27, Issue 3, Pages (September 2007)
Volume 36, Issue 4, Pages (April 2012)
Volume 33, Issue 5, Pages (November 2010)
Volume 12, Issue 4, Pages (October 2012)
Volume 32, Issue 2, Pages (February 2010)
Volume 42, Issue 1, Pages (January 2015)
Volume 40, Issue 4, Pages (April 2014)
Targeted Cleavage of Signaling Proteins by Caspase 3 Inhibits T Cell Receptor Signaling in Anergic T Cells  Irene Puga, Anjana Rao, Fernando Macian  Immunity 
Volume 33, Issue 1, Pages (July 2010)
Volume 35, Issue 4, Pages (October 2011)
Volume 68, Issue 3, Pages e5 (November 2017)
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 26, Issue 3, Pages (March 2007)
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
Volume 156, Issue 4, Pages (February 2014)
Volume 31, Issue 5, Pages (November 2009)
Suman Paul, Anuj K. Kashyap, Wei Jia, You-Wen He, Brian C. Schaefer 
Volume 23, Issue 2, Pages (August 2005)
Volume 65, Issue 5, Pages e4 (March 2017)
Presentation transcript:

Volume 39, Issue 4, Pages 711-721 (October 2013) Processing of Human Toll-like Receptor 7 by Furin-like Proprotein Convertases Is Required for Its Accumulation and Activity in Endosomes  Madeleine M. Hipp, Dawn Shepherd, Uzi Gileadi, Michael C. Aichinger, Benedikt M. Kessler, Mariola J. Edelmann, Rachid Essalmani, Nabil G. Seidah, Caetano Reis e Sousa, Vincenzo Cerundolo  Immunity  Volume 39, Issue 4, Pages 711-721 (October 2013) DOI: 10.1016/j.immuni.2013.09.004 Copyright © 2013 Elsevier Inc. Terms and Conditions

Immunity 2013 39, 711-721DOI: (10.1016/j.immuni.2013.09.004) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 A Truncated C-Terminal Fragment of TLR7 Is Present in Different Human Cell Lines (A) HA-tagged proteins from THP-, 293null-, or LoVo-TLR7 cell lysates were analyzed by immunoblot with anti-HA. Representative of more than three independent experiments. Full-length and truncated TLR7 are shown by filled and open arrowheads, respectively. (B) Comparison of immunoblot and silver staining of proteins immunoprecipitated with anti-HA from THP-TLR7 or THP-GFP treated with PMA for 24 hr. Box indicates polypeptides analyzed by nano LC-ESIMS/MS tandem mass spectrometry. MS analysis was performed once. (C) Top: hTLR7 sequence, with peptides identified by MS analysis highlighted in black. The undefined region predicted by Bell et al. (2003) is shown in blue. Potential furin-like PC recognition sites are underlined. Arginine and lysine residues within those sites are shown in red. Bottom: Alignment of the potential PC recognition sites close to the undefined region within the hTLR7 and mTLR7 sequences. Immunity 2013 39, 711-721DOI: (10.1016/j.immuni.2013.09.004) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Proinflammatory Stimuli Enhance TLR7 Processing and Responses to TLR7 Agonists (A–C) Immunoblot analysis of cell lysates from THP-TLR7 treated for 24 hr with 10 nM PMA, 200 U/ml IFN-γ (A), 1,000 U/ml IFN-α (B), or LPS (C). Intensity of truncated TLR7 band is expressed as percentage of the truncated + full-length TLR7 bands. (A and B) THP-TLR7 were differentiated with PMA, IFN-γ, or IFN-α as above and then stimulated with R837 for another 24 hr. Values are mean ± SD of triplicates. ∗∗∗∗p < 0.0001 versus control by Student’s t test. (D) Phagosomes were isolated from THP-TLR7 fed with or without latex beads in the presence of R837. Lysates of pregradient (Pre) controls or phagosome (Phag) were analyzed by immunoblot. Full-length and truncated TLR7 are shown by filled and open arrowheads, respectively. Representative of at least three independent experiments. See also Figure S1. Immunity 2013 39, 711-721DOI: (10.1016/j.immuni.2013.09.004) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 Inhibition of Acidification Does Not Affect the Generation of Truncated TLR7 and Its Accumulation in Phagosomes (A) Immunoblot analysis of lysates of pregradient controls (Pre) or phagosome (Phag) fractions probed with antibodies with the indicated specificity. PMA-differentiated THP-TLR7 cells were treated with indicated inhibitors for 12 hr before feeding with latex beads in the presence of inhibitors and R837 for 6 hr. (B) PMA-differentiated THP-TLR7 were treated with indicated inhibitors (E64 [20 μM], CatS [2 nM], CatK [1.5 μM], EST [20 μM]) or carrier (ethanol; EtOH) for 24 hr. Phagosomes were isolated and analyzed as described above. Full-length and truncated TLR7 are shown by filled and open arrowheads, respectively. Asterisk (∗) indicates immature pro-CatB and hatch sign (#) indicates mature CatB. (C) PMA-differentiated THP-TLR7 cells were treated with the indicated inhibitors for 24 hr and then stimulated with R837 or LPS in the presence of inhibitors for another 24 hr. IL-8 accumulation in culture supernatants was measured by ELISA. Values are mean ± SD of triplicates. ns indicates nonsignificant versus control by Student’s t test. Representative of at least three independent experiments. See also Figure S2. Immunity 2013 39, 711-721DOI: (10.1016/j.immuni.2013.09.004) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 Calcium-Dependent Serine-Proteases Mediate TLR7 Processing (A–C) Immunoblot analysis of cell lysates of PMA-differentiated THP-TLR7 treated with AEBSF (0.25 mM) (A), EDTA (0.5 mM) + A23187 (0.5 μM) (B), or DC1 (60 μM) (C) for 24 hr. Membranes were probed with the indicated antibodies. Band intensity is expressed as percentage of total TLR7. For cytokine analysis, cells were treated as described above and then stimulated with R837 or LPS in the presence of inhibitors for another 24 hr and IL-8 in culture supernatants was measured by ELISA. Values are mean ± SD of triplicates. ns indicates nonsignificant; ∗p < 0.05 versus control by Student’s t test. (D) Immunoblot analysis of lysates of pregradient controls (Pre) or phagosome fractions (Phag) probed with antibodies specific for the indicated proteins. PMA-differentiated THP-TLR7 cells were treated with inhibitors 24 hr prior to incubation with latex beads in the presence of R837. Full-length and truncated TLR7 are shown by filled and open arrowheads, respectively. Representative of at least three independent experiments. See also Figure S3. Immunity 2013 39, 711-721DOI: (10.1016/j.immuni.2013.09.004) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 5 Furin, PC5/6, and PC7 Can Mediate TLR7 Processing (A–C) LoVo-TLR7 cells stably expressing IRES control plasmid, or inhibitory preprosegments ppPc7 or ppPc5, or ppPc7 and ppPc5 (ppPc5/7) together. (A) Semiquantitative RT-PCR showing expression of preprosegments. (B) IL-8 in supernatants of LoVo-TLR7 expressing the indicated preprosegments and stimulated for 24 hr with R848. (C) Immunoblots of cell lysates of LoVo-TLR7 expressing ppPc5 and ppPc7 and stained for HA. Band intensity is expressed as percentage of total TLR7. (D) Immunoblot of cell lysates of THP-TLR7 expressing shRNA against furin or nontarget controls stained for HA and furin (top). Band intensity is expressed as percentage of total TLR7 (top right). IL-8 in supernatant of the same cells stimulated for 24 hr with R837 (1 μg/ml) or LPS (0.1 μg/ml) (bottom). (E) Schematic depiction of TLR7 and TLR7-mut. The flexible loop is depicted in gray. Mutation inserted within the flexible loop indicated by x. (F) Cell lysates of PMA-differentiated THP-1 expressing indicated constructs were analyzed by staining with anti-HA. IL-8 accumulation in culture supernatants of indicated cell lines was monitored by ELISA after 24 hr of stimulation with R837 (10 μg/ml). All IL-8 histograms show mean ± SD (n = 3). ns indicates nonsignificant; ∗p < 0.05; ∗∗p < 0.01 by Student’s t test versus control. Full-length and truncated TLR7 are shown by filled and open arrowheads, respectively. Representative of either two (A) or at least three (B–D, F) independent experiments. See also Figure S4. Immunity 2013 39, 711-721DOI: (10.1016/j.immuni.2013.09.004) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 6 The Truncated Version of TLR7 Is Signaling Competent (A) IL-8 secretion from THP-1 cells expressing the indicated constructs stimulated with R837 for 24 hr was measured by an ELISA. Values are mean ± SD (n = 3). (B and C) THP-1 cells expressing HA-tagged TLR7 and FLAG-tagged MyD88 were PMA differentiated for 24 hr in the presence of DMSO or DC1 (70 μm) and then stimulated for 3 hr with 5 μg/ml R837. (B) Cells were then fixed and stained with anti-HA (shown in red) and anti-FLAG (shown in green). Confocal pictures were taken. Scale bars represent 5 μm (top three rows) and 1 μm (bottom row). (C) Li’s coefficient of ≥10 cells per treatment was calculated to quantify the degree of colocalization of MyD88 and TLR7. Data obtained are represented as a box and whisker plot. Whiskers show minimum to maximum of all the data. Stats versus control (Student’s t test): ∗∗p < 0.01; ∗∗∗p < 0.001. Representative of three independent experiments. See also Figure S5. Immunity 2013 39, 711-721DOI: (10.1016/j.immuni.2013.09.004) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 7 Pharmacological Inhibition of Furin-like PCs in pDCs and B Cells Reduces Responses to TLR7 and TLR9 Agonists (A) Human pDC fractions were treated with DMSO or DC1 (70 μM) for 24 hr and then stimulated with R837 (1 μg/ml) or hiFlu (equivalent to MOIs of 0.5 or 1) overnight. IFN-α in supernatants was measured by ELISA. Histograms show mean ± SD (n = 2). (B) Human IFN-DCs were treated with DC1 (30 μm) for 24 hr and then stimulated with R837 (2.5 or 5 μg/ml) or LPS (0.5 μg/ml) for 36 hr. Supernatants were harvested and IL-8 content was measured. Histograms show mean ± SD (n = 3). (C) Human blood B cells were treated with DMSO or DC1 (70 μM) for 24 hr and then stimulated with R837 (10 μg/ml) or hiFlu (equivalent to MOI of 1.6) for another 24 hr. IL-8 in supernatants was measured by ELISA (left) and upregulation of CD80 was analyzed by FACS (right). Values are mean ± SD of triplicates. (D) Human pDC fractions were treated with DMSO or DC1 (70 μM) for 24 hr, and then stimulated with CpG-A (5 μg/ml) overnight. IFN-α secretion was measured by ELISA. Values are mean ± SD of duplicates. (E) Human blood B cells were treated with DMSO or DC1 (70 μM) for 24 hr and then stimulated with anti-Fab alone or with anti-Fab ± CpG-B (5 μM) for 24 hr. Upregulation of cell surface expressed CD80 was analyzed by flow cytometry. ns indicates nonsignificant; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 by Student’s t test versus control. Representative of either at least three (A, B) or two (C–E) independent experiments. See also Figure S6. Immunity 2013 39, 711-721DOI: (10.1016/j.immuni.2013.09.004) Copyright © 2013 Elsevier Inc. Terms and Conditions